NCT07090499 2026-03-19A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPfizerPhase 1 Recruiting310 enrolled
NCT07115043 2026-03-17A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsAstraZenecaPhase 1/2 Recruiting60 enrolled
NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT06147037 2026-03-03A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid TumoursAstraZenecaPhase 1 Recruiting70 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT04895709 2026-02-25A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsBristol-Myers SquibbPhase 1/2 Recruiting949 enrolled
NCT06546553 2026-02-23A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.PfizerPhase 1 Terminated10 enrolled